cheqfx
Advertisement · 728×90
‹ All stocks
PRPH

ProPhase Labs

PRPH · NASDAQ · Healthcare
$0.01
▼ $0.00 (-7.17%)
$-0.99 $-0.32 $0.34 $1.01 $0.01 Oct 2026 Oct 2026
Day range
$0.01 – $0.02
Year range
$0.01 – $6.66
Open
$0.01
Previous close
$0.01
Market cap
$156.14K
Volume (24h)
$1.2M
Volume (52w)
$12.83K
Performance
7D
▲ 34.22%
1M
▼ -36.70%
3M
▼ -85.34%
6M
▼ -88.86%
1Y
▼ -99.81%
YTD
▼ -96.91%
3Y
▼ -99.95%
5Y
▼ -99.96%
All-time
▼ -99.55%
Key statistics
P/E ratio
0.00
EPS (TTM)
$-2.39
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
14.0M
About ProPhase Labs

ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.

Visit website
Country: United States of America
More in Healthcare